Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 28% ± 5% | |
ciliated cell | 5 studies | 28% ± 11% |
Insufficient scRNA-seq data for expression of PWWP2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3635.86 | 258 / 258 | 100% | 70.86 | 230 / 230 |
pancreas | 100% | 2525.86 | 328 / 328 | 100% | 43.76 | 178 / 178 |
thymus | 100% | 1831.90 | 653 / 653 | 100% | 44.56 | 604 / 605 |
esophagus | 100% | 1543.76 | 1445 / 1445 | 99% | 26.16 | 182 / 183 |
stomach | 100% | 1518.45 | 359 / 359 | 99% | 32.88 | 284 / 286 |
ovary | 99% | 974.53 | 179 / 180 | 100% | 37.27 | 429 / 430 |
prostate | 100% | 1493.53 | 245 / 245 | 99% | 55.21 | 498 / 502 |
uterus | 100% | 1198.58 | 170 / 170 | 99% | 40.25 | 453 / 459 |
intestine | 100% | 1784.81 | 966 / 966 | 99% | 39.54 | 520 / 527 |
bladder | 100% | 1507.10 | 21 / 21 | 98% | 56.70 | 495 / 504 |
breast | 100% | 1305.86 | 459 / 459 | 98% | 35.41 | 1094 / 1118 |
lung | 100% | 1453.59 | 576 / 578 | 98% | 30.25 | 1129 / 1155 |
brain | 97% | 1363.61 | 2551 / 2642 | 89% | 11.83 | 625 / 705 |
skin | 96% | 1390.64 | 1744 / 1809 | 86% | 17.27 | 407 / 472 |
kidney | 99% | 1102.70 | 88 / 89 | 71% | 10.36 | 638 / 901 |
liver | 66% | 333.63 | 149 / 226 | 77% | 19.02 | 311 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 57.96 | 80 / 80 |
muscle | 100% | 1581.77 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3371.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 74.72 | 1 / 1 |
adipose | 100% | 1219.42 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 805.21 | 831 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 15.14 | 27 / 29 |
blood vessel | 86% | 476.14 | 1152 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 847.88 | 770 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0120161 | Biological process | regulation of cold-induced thermogenesis |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0120325 | Molecular function | NuRD complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PWWP2B |
Protein name | PWWP domain-containing protein 2B |
Synonyms | PWWP2 |
Description | FUNCTION: Chromatin-binding protein that acts as an adapter between distinct nucleosome components (H3K36me3 or H2A.Z) and chromatin-modifying complexes, contributing to the regulation of the levels of histone acetylation at actively transcribed genes . Competes with CHD4 and MBD3 for interaction with MTA1 to form a NuRD subcomplex, preventing the formation of full NuRD complex (containing CHD4 and MBD3), leading to recruitment of HDACs to gene promoters resulting in turn in the deacetylation of nearby H3K27 and H2A.Z . Plays a role in facilitating transcriptional elongation through regulation of histone acetylation (By similarity). Negatively regulates brown adipocyte thermogenesis by interacting with and stabilizing HDAC1 at the UCP1 gene promoter, thereby promoting histone deacetylation at the promoter leading to the repression of UCP1 expression (By similarity). . |
Accessions | ENST00000305233.6 [Q6NUJ5-1] Q6NUJ5 ENST00000631148.2 [Q6NUJ5-2] |